6-KThe Wire
Telix Pharmaceuticals Ltd files 6-K
Filed Apr 2, 2026 · 3mo ago · Accession 0002007191-26-000015
Plain English
Telix Pharmaceuticals Limited announced the appointment of David Gill as a Non-Executive Director on April 2, 2026. This information is incorporated by reference into the company's Registration Statements on Form F-3ASR and Form S-8.
Filing details
- Company
- Telix Pharmaceuticals Ltd
- Ticker
- TLX
- CIK
- 2007191
- Form type
- 6-K
- Filing date
- Apr 2, 2026
- Report date
- Apr 1, 2026
- Document
- k6gill.htm
- Size
- 75 KB
More from TLX
6-KThe WireJul 2, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSMay 21, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 23, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 21, 20266-KCURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTSApr 20, 20266-KThe WireApr 14, 2026